ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CRMD CorMedix Inc

5.3701
-0.1499 (-2.72%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
CorMedix Inc CRMD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.1499 -2.72% 5.3701 09:53:19
Open Price Low Price High Price Close Price Previous Close
5.53 5.2799 5.5884 5.37 5.52
more quote information »

Recent News

Date Time Source Heading
19/4/202422:30GLOBECorMedix Inc. Announces CMS Grants TDAPA to DefenCath
15/4/202422:30GLOBECorMedix Inc. Announces U.S. Inpatient Commercial..
12/3/202422:30GLOBECorMedix Inc. Reports Fourth Quarter and Full Year 2023..
31/1/202409:26EDGAR2Form 8-K - Current report
19/1/202408:53EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
18/1/202412:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:39EDGAR2Form 8-K - Current report
15/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202308:11EDGAR2Form 8-K - Current report
15/11/202308:05GLOBECorMedix Inc. Reports Third Quarter and Nine Month 2023..
31/10/202307:35EDGAR2Form 8-K - Current report
11/10/202323:30GLOBECorMedix Inc. Announces Abstract Presentation at Upcoming..
14/9/202307:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/9/202307:20EDGAR2Form DEF 14A - Other definitive proxy statements
09/9/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:30GLOBECorMedix Inc. Announces Publication of Phase 3 LOCK IT-100..
30/8/202322:00GLOBECorMedix Inc. Announces Issuance of U.S. Patent Covering..
17/8/202322:30EDGAR2Form 8-K - Current report
08/8/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202321:45EDGAR2Form 8-K - Current report
08/8/202321:30GLOBECorMedix Inc. Reports Second Quarter and Six Month 2023..
01/7/202306:40EDGAR2Form 8-K - Current report
01/7/202306:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/6/202312:57GLOBECorMedix Inc. Announces Pricing of $40 Million Public..
29/6/202307:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/6/202306:07GLOBECorMedix Inc. Announces Proposed Public Offering of Common..
21/6/202322:30GLOBECorMedix Inc. Announces FDA Acceptance of Resubmission of..
15/6/202322:30GLOBECormedix Inc. Announces Strategic Initiative With Boston..
16/5/202321:00GLOBECorMedix Inc. Announces Resubmission of New Drug Application..
16/5/202306:05GLOBECorMedix Inc. Reports First Quarter 2023 Financial Results..

Your Recent History

Delayed Upgrade Clock